{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:21:13Z","timestamp":1787790073240,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2021-124632OB-100"],"award-info":[{"award-number":["PID2021-124632OB-100"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["Juan de la Cierva"],"award-info":[{"award-number":["Juan de la Cierva"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["FPU"],"award-info":[{"award-number":["FPU"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2020-118527RB-I00"],"award-info":[{"award-number":["PID2020-118527RB-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2023-153081OB-I00"],"award-info":[{"award-number":["PID2023-153081OB-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Ministry of Economy and Competitiveness | Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["FPU"],"award-info":[{"award-number":["FPU"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02894-z","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:02:16Z","timestamp":1787788936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A RAC1 SUMOylation switch governs breast cancer metastasis"],"prefix":"10.1038","volume":"11","author":[{"given":"Ana","family":"Garc\u00eda-Casas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Garc\u00eda-Sancha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Corchado-Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mart\u00edn-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9lida","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8370-1336","authenticated-orcid":false,"given":"Manuel Adolfo","family":"S\u00e1nchez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2573-8709","authenticated-orcid":false,"given":"Marina","family":"Mendiburu-Eli\u00e7abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gonz\u00e1lez-Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5407-3123","authenticated-orcid":false,"given":"Robert B.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Malliri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"P\u00e9rez-Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-7178","authenticated-orcid":false,"given":"Sonia","family":"Castillo-Lluva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2894_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"2894_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Prim. 5, 66 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2894_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160\u20131167 (2009).","journal-title":"J. Clin. Oncol."},{"key":"2894_CR4","doi-asserted-by":"publisher","first-page":"194990","DOI":"10.1016\/j.bbagrm.2023.194990","volume":"1866","author":"AH Shukri","year":"2023","unstructured":"Shukri, A. H., Lukinovic, V., Charih, F. & Biggar, K. K. Unraveling the battle for lysine: a review of the competition among post-translational modifications. Biochim. Biophys. Acta Gene Regul. Mech. 1866, 194990 (2023).","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"2894_CR5","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.molcel.2021.03.015","volume":"81","author":"EK Keenan","year":"2021","unstructured":"Keenan, E. K., Zachman, D. K. & Hirschey, M. D. Discovering the landscape of protein modifications. Mol. Cell 81, 1868\u20131878 (2021).","journal-title":"Mol. Cell"},{"key":"2894_CR6","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/febs.15319","volume":"287","author":"AB Celen","year":"2020","unstructured":"Celen, A. B. & Sahin, U. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J. 287, 3110\u20133140 (2020).","journal-title":"FEBS J."},{"key":"2894_CR7","first-page":"1081","volume":"52","author":"ZJ Han","year":"2018","unstructured":"Han, Z. J., Feng, Y. H., Gu, B. H., Li, Y. M. & Chen, H. The post-translational modification, SUMOylation, and cancer (Review). Int. J. Oncol. 52, 1081\u20131094 (2018).","journal-title":"Int. J. Oncol."},{"key":"2894_CR8","doi-asserted-by":"crossref","unstructured":"Yau, T. Y., Sander, W., Eidson, C. & Courey, A. J. SUMO interacting motifs: structure and function. Cells 10, 2825 (2021).","DOI":"10.3390\/cells10112825"},{"key":"2894_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1083\/jcb.201612069","volume":"217","author":"CD Lawson","year":"2018","unstructured":"Lawson, C. D. & Ridley, A. J. Rho GTPase signaling complexes in cell migration and invasion. J. Cell Biol. 217, 447\u2013457 (2018).","journal-title":"J. Cell Biol."},{"key":"2894_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/BST20170531","volume":"46","author":"XR Bustelo","year":"2018","unstructured":"Bustelo, X. R. RHO GTPases in cancer: known facts, open questions, and therapeutic challenges. Biochem. Soc. Trans. 46, 741\u2013760 (2018).","journal-title":"Biochem. Soc. Trans."},{"key":"2894_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.4161\/cc.10.10.15612","volume":"10","author":"NA Mack","year":"2011","unstructured":"Mack, N. A., Whalley, H. J., Castillo-Lluva, S. & Malliri, A. The diverse roles of Rac signaling in tumorigenesis. Cell Cycle 10, 1571\u20131581 (2011).","journal-title":"Cell Cycle"},{"key":"2894_CR12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/onc.2012.189","volume":"32","author":"S Castillo-Lluva","year":"2013","unstructured":"Castillo-Lluva, S., Tan, C. T., Daugaard, M., Sorensen, P. H. & Malliri, A. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation. Oncogene 32, 1735\u20131742 (2013).","journal-title":"Oncogene"},{"key":"2894_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ncb2112","volume":"12","author":"S Castillo-Lluva","year":"2010","unstructured":"Castillo-Lluva, S. et al. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat. Cell Biol. 12, 1078\u20131085 (2010).","journal-title":"Nat. Cell Biol."},{"key":"2894_CR14","doi-asserted-by":"crossref","unstructured":"Lorente, M. et al. Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1. J. Cell Sci. 132, jcs234120 (2019).","DOI":"10.1242\/jcs.234120"},{"key":"2894_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0329-5","volume":"32","author":"R Leng","year":"2015","unstructured":"Leng, R., Liao, G., Wang, H., Kuang, J. & Tang, L. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome. Med. Oncol. 32, 329 (2015).","journal-title":"Med. Oncol."},{"key":"2894_CR16","doi-asserted-by":"publisher","first-page":"e18445","DOI":"10.1097\/MD.0000000000018445","volume":"99","author":"Y Lin","year":"2020","unstructured":"Lin, Y. et al. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis. Medecine 99, e18445 (2020).","journal-title":"Medecine"},{"key":"2894_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bbrc.2009.06.125","volume":"386","author":"J Wang","year":"2009","unstructured":"Wang, J. et al. Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth. Biochem. Biophys. Res. Commun. 386, 769\u2013774 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2894_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0092-8674(92)90164-8","volume":"70","author":"AJ Ridley","year":"1992","unstructured":"Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D. & Hall, A. The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell. 70, 401\u2013410 (1992).","journal-title":"Cell."},{"key":"2894_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.674426","volume":"11","author":"J Liang","year":"2021","unstructured":"Liang, J. et al. Rac1, A potential target for tumor therapy. Front. Oncol. 11, 674426 (2021).","journal-title":"Front. Oncol."},{"key":"2894_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2217\/fon-2020-0221","volume":"16","author":"X Wang","year":"2020","unstructured":"Wang, X., Yao, Y. & Gao, J. Sevoflurane inhibits growth factor-induced angiogenesis through suppressing Rac1\/paxillin\/FAK and Ras\/Akt\/mTOR. Future Oncol. 16, 1619\u20131627 (2020).","journal-title":"Future Oncol."},{"key":"2894_CR21","first-page":"190","volume":"130","author":"L Li","year":"2017","unstructured":"Li, L. et al. Increased ROS production in non-polarized mammary epithelial cells induces monocyte infiltration in 3D culture. J. Cell Sci. 130, 190\u2013202 (2017).","journal-title":"J. Cell Sci."},{"key":"2894_CR22","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1038\/sj.onc.1208503","volume":"24","author":"ME Minard","year":"2005","unstructured":"Minard, M. E., Herynk, M. H., Collard, J. G. & Gallick, G. E. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 24, 2568\u20132573 (2005).","journal-title":"Oncogene"},{"key":"2894_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/1878-0261.13568","volume":"18","author":"A Martinez-Lopez","year":"2024","unstructured":"Martinez-Lopez, A. et al. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1. Mol. Oncol. 18, 620\u2013640 (2024).","journal-title":"Mol. Oncol."},{"key":"2894_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62279-2","volume":"10","author":"A Lopez-Cortes","year":"2020","unstructured":"Lopez-Cortes, A. et al. OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine. Sci. Rep. 10, 5285 (2020).","journal-title":"Sci. Rep."},{"key":"2894_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/21541248.2016.1173767","volume":"7","author":"AP Porter","year":"2016","unstructured":"Porter, A. P., Papaioannou, A. & Malliri, A. Deregulation of Rho GTPases in cancer. Small GTPases 7, 123\u2013138 (2016).","journal-title":"Small GTPases"},{"key":"2894_CR26","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.1158\/0008-5472.CAN-06-2071","volume":"66","author":"SE Wang","year":"2006","unstructured":"Wang, S. E., Shin, I., Wu, F. Y., Friedman, D. B. & Arteaga, C. L. HER2\/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta. Cancer Res. 66, 9591\u20139600 (2006).","journal-title":"Cancer Res."},{"key":"2894_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.molcel.2010.11.029","volume":"40","author":"MS Sosa","year":"2010","unstructured":"Sosa, M. S. et al. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol. Cell. 40, 877\u2013892 (2010).","journal-title":"Mol. Cell."},{"key":"2894_CR28","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","volume":"89","author":"CT Guy","year":"1992","unstructured":"Guy, C. T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89, 10578\u201310582 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2894_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1074\/jbc.M110.164384","volume":"286","author":"MK Mittal","year":"2011","unstructured":"Mittal, M. K., Singh, K., Misra, S. & Chaudhuri, G. SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J. Biol. Chem. 286, 469\u2013479 (2011).","journal-title":"J. Biol. Chem."},{"key":"2894_CR30","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1038\/onc.2014.328","volume":"34","author":"LM Dillon","year":"2015","unstructured":"Dillon, L. M. et al. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K\/AKT and MEK\/ERK signaling in breast cancer. Oncogene 34, 3968\u20133976 (2015).","journal-title":"Oncogene"},{"key":"2894_CR31","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1242\/jcs.062679","volume":"123","author":"JR Halstead","year":"2010","unstructured":"Halstead, J. R. et al. Rac controls PIP5K localisation and PtdIns(4,5)P(2) synthesis, which modulates vinculin localisation and neurite dynamics. J. Cell Sci. 123, 3535\u20133546 (2010).","journal-title":"J. Cell Sci."},{"key":"2894_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1126\/science.279.5350.509","volume":"279","author":"A Hall","year":"1998","unstructured":"Hall, A. Rho GTPases and the actin cytoskeleton. Science 279, 509\u2013514 (1998).","journal-title":"Science"},{"key":"2894_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2006.10.031","volume":"117","author":"A Chauhan","year":"2007","unstructured":"Chauhan, A., Tikoo, A., Kapur, A. K. & Singh, M. The taming of the cell penetrating domain of the HIV Tat: myths and realities. J. Control Release. 117, 148\u2013162 (2007).","journal-title":"J. Control Release."},{"key":"2894_CR34","doi-asserted-by":"publisher","first-page":"13228","DOI":"10.1074\/jbc.M111.334524","volume":"287","author":"BL Montalvo-Ortiz","year":"2012","unstructured":"Montalvo-Ortiz, B. L. et al. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. J. Biol. Chem. 287, 13228\u201313238 (2012).","journal-title":"J. Biol. Chem."},{"key":"2894_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1083\/jcb.200509096","volume":"172","author":"JP ten Klooster","year":"2006","unstructured":"ten Klooster, J. P., Jaffer, Z. M., Chernoff, J. & Hordijk, P. L. Targeting and activation of Rac1 are mediated by the exchange factor beta-Pix. J. Cell Biol. 172, 759\u2013769 (2006).","journal-title":"J. Cell Biol."},{"key":"2894_CR36","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1128\/MCB.18.2.762","volume":"18","author":"KF Tolias","year":"1998","unstructured":"Tolias, K. F., Couvillon, A. D., Cantley, L. C. & Carpenter, C. L. Characterization of a Rac1- and RhoGDI-associated lipid kinase signaling complex. Mol. Cell Biol. 18, 762\u2013770 (1998).","journal-title":"Mol. Cell Biol."},{"key":"2894_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0960-9822(00)00315-8","volume":"10","author":"KF Tolias","year":"2000","unstructured":"Tolias, K. F. et al. Type Ialpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly. Curr. Biol. 10, 153\u2013156 (2000).","journal-title":"Curr. Biol."},{"key":"2894_CR38","doi-asserted-by":"crossref","unstructured":"Bartha, A. & Gyorffy, B. TNMplot: an enhanced platform for pharmacological target identification through cross-stage and pan-cancer gene expression analysis. Br. J. Pharmacol. 183, 2648\u20132659 (2026).","DOI":"10.1111\/bph.70390"},{"key":"2894_CR39","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1111\/bph.70215","volume":"182","author":"M Posta","year":"2025","unstructured":"Posta, M. & Gyorffy, B. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. Br. J. Pharm. 182, 5734\u20135747 (2025).","journal-title":"Br. J. Pharm."},{"key":"2894_CR40","doi-asserted-by":"crossref","unstructured":"Mosaddeghzadeh, N. & Ahmadian, M. R. The RHO family GTPases: mechanisms of regulation and signaling. Cells 10, 1831 (2021).","DOI":"10.3390\/cells10071831"},{"key":"2894_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/21541248.2016.1211398","volume":"8","author":"H Marei","year":"2017","unstructured":"Marei, H. & Malliri, A. Rac1 in human diseases: the therapeutic potential of targeting Rac1 signaling regulatory mechanisms. Small GTPases 8, 139\u2013163 (2017).","journal-title":"Small GTPases"},{"key":"2894_CR42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s12282-020-01091-2","volume":"27","author":"M Yamaguchi","year":"2020","unstructured":"Yamaguchi, M. et al. Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance. Breast Cancer 27, 919\u2013928 (2020).","journal-title":"Breast Cancer"},{"key":"2894_CR43","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1038\/sj.onc.1203621","volume":"19","author":"A Schnelzer","year":"2000","unstructured":"Schnelzer, A. et al. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19, 3013\u20133020 (2000).","journal-title":"Oncogene"},{"key":"2894_CR44","doi-asserted-by":"publisher","first-page":"1240115","DOI":"10.3389\/fonc.2023.1240115","volume":"13","author":"H Dutta","year":"2023","unstructured":"Dutta, H. & Jain, N. Post-translational modifications and their implications in cancer. Front. Oncol. 13, 1240115 (2023).","journal-title":"Front. Oncol."},{"key":"2894_CR45","doi-asserted-by":"crossref","unstructured":"Kukkula, A. et al. Therapeutic potential of targeting the SUMO pathway in cancer. Cancers 13, 4402 (2021).","DOI":"10.3390\/cancers13174402"},{"key":"2894_CR46","doi-asserted-by":"crossref","unstructured":"Martinez-Lopez, A. et al. SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts. Cell Oncol.) 48, 437\u2013453 (2025).","DOI":"10.1007\/s13402-024-01005-w"},{"key":"2894_CR47","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","volume":"64","author":"SP Langston","year":"2021","unstructured":"Langston, S. P. et al. Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer. J. Med. Chem. 64, 2501\u20132520 (2021).","journal-title":"J. Med. Chem."},{"key":"2894_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2021.08.014","volume":"521","author":"A Martinez-Lopez","year":"2021","unstructured":"Martinez-Lopez, A. et al. Inhibition of RAC1 activity in cancer associated fibroblasts favours breast tumour development through IL-1beta upregulation. Cancer Lett. 521, 14\u201328 (2021).","journal-title":"Cancer Lett."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02894-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02894-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02894-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:02:19Z","timestamp":1787788939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02894-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02894-z","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"350"}}